Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions

International Journal of Molecular Sciences

Victor M. Quiroz¹  Joshua C. Doloff¹  Sarah Y. Neshat¹  Yuanjia Wang¹  Sebastian Tamayo¹ 

[1] Department of Biomedical Engineering, Translational Tissue Engineering Center, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA;

关键词: mesenchymal stem cells;    cirrhosis;    fibrosis;    alcoholic liver disease;    non-alcoholic fatty liver disease;    in vivo;   

DOI  :  10.3390/ijms22136777

来源: DOAJ

【 摘 要 】

The liver is an organ with impressive regenerative potential and has been shown to heal sizable portions after their removal. However, certain diseases can overstimulate its potential to self-heal and cause excessive cellular matrix and collagen buildup. Decompensation of liver fibrosis leads to cirrhosis, a buildup of fibrotic ECM that impedes the liver’s ability to efficiently exchange fluid. This review summarizes the complex immunological activities in different liver diseases, and how failure to maintain liver homeostasis leads to progressive fibrotic tissue development. We also discuss a variety of pathologies that lead to liver cirrhosis, such as alcoholic liver disease and chronic hepatitis B virus (HBV). Mesenchymal stem cells are widely studied for their potential in tissue replacement and engineering. Herein, we discuss the potential of MSCs to regulate immune response and alter the disease state. Substantial efforts have been performed in preclinical animal testing, showing promising results following inhibition of host immunity. Finally, we outline the current state of clinical trials with mesenchymal stem cells and other cellular and non-cellular therapies as they relate to the detection and treatment of liver cirrhosis.

【 授权许可】

Unknown